1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. DR. REDDY'S LABORATORIES LTD.
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY | BSE: 500124
US FDA InspectionsANDA Approvals
Ask AI about Dr. Reddy's Labs
1400.902.70(0.19%)
1.5M
NSE+BSE Volume

NSE 19 Nov, 2026 3:31 PM

Portfolio

Alert

My Notes

Dr. Reddy's Labs quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Dr. Reddy's Labs share price target, revenues, EPS, net income and more

Dr. Reddy's Labs quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Dr. Reddy's Labs Sep-2026 Quarterly Revenue is Rs 5,790 Cr which is growth of 16.2% YoY.

  • POSITIVE

    Quarterly Net Profit Dr. Reddy's Labs Sep-2026 Quarterly Net Profit is Rs 696 Cr which is growth of 79.7% YoY.

Dr. Reddy's Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23
⌄
5,789.95,5774,389.24,6434,982.88,207.85,977.35,250.46,903.96,0595,317.54,330.65,061.8
Operating Exp.
4,489.44,687.74,200.84,183.14,138.33,972.54,016.33,822.63,974.73,888.23,700.23,446.73,209.6
Operating Profit
1,094.7447.4-499.999.6480.33,8371,4431,192.42,721.61,9531,378.6656.31,629.1
Operating Profit Margin %
19.64%8.71%-13.08%2.33%10.40%49.13%25.94%23.78%40.64%33.43%27.01%16.00%33.67%
Depr.
333.7317.7318.5314.3294.8279.8264.5265.1260249.8246.2246.4245.8
Interest
7773.154.341.433.419.231.143.328.47.15.95.65.8
Profit Before Tax
901.3497-305.5104.2516.33,936.31,561.81,119.42,640.81,913.91,339.2631.91,600.6
Tax
205.592.3-86.113.6129975.1361.1270758.7496.7304.4156.7408
Net Profit
695.8404.7-219.490.6387.32,961.21,200.7849.41,882.11,417.21,034.8475.21,192.6
EPS Adj. latest
8.34.9-2.61.14.635.514.410.222.61712.45.714.3
Net profit TTM
971.7663.23,219.74,639.85,398.66,893.45,349.45,183.54,809.34,119.84,3423,979.63,829
Basic EPS TTM
11.67.938.655.664.782.664.162.2288.3247260.3238.6229.6
Earnings Transcripts
Results PDF
Result Notes
 
*All financials are in INR Cr and price data in INR

Dr. Reddy's Labs competitor comparison and performance snapshot within industry

Dr. Reddy's Labs revenue mix: sales, profit, and capital employed breakups by segment

Dr. Reddy's Labs annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

  • NEGATIVE

    Annual Revenue Dr. Reddy's Labs Mar-2026 Annual Revenue is Rs 22,222 Cr which is growth of -7.9% YoY.

  • NEGATIVE

    Annual Net Profit Dr. Reddy's Labs Mar-2026 Annual Net Profit is Rs 3,220 Cr which is growth of -39.8% YoY.

Dr. Reddy's Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
8.2%
9.4%
20,399.122,222.424,118.820,346.117,553.814,887.214,150.212,593.610,863.99,563.310,31110,452.5
Operating Exp. Ann.
9.2%
10.2%
17,56116,615.415,733.613,557.412,747.711,811.110,212.38,980.88,325.88,029.47,974.27,803.7
Operating Profit Ann.
-2.4%
4.5%
1,141.83,917.47,381.85,926.44,214.82,594.13,136.82,869.62,299.71,329.91,745.62,404
OPM Ann. %
-9.8%
-4.5%
 17.63%30.61%29.13%24.01%17.43%22.17%22.79%21.17%13.91%16.93%23.00%
⌄
9.5%
10.1%
 17,971.116,882.914,554.813,687.812,663.411,0949,817.89,163.28,866.38,766.58,516.6
EBITDA Ann.
5.3%
7.3%
 5,6078,385.26,788.74,806.13,076.13,937.93,612.82,538.11,533.92,336.82,648.8
EBITDA Ann. margin %
-2.7%
-1.9%
 25.23%34.77%33.37%27.38%20.66%27.83%28.69%23.36%16.04%22.66%25.34%
Interest Ann.
106.3%
26%
245.8148.3109.921.816.93846.747.856.862.857.263.8
Depr.
9.4%
7.7%
1,284.21,207.41,039.4975.6923.2814.3835789.2780.6774.1735.1649.1
PBT Ann.
3.2%
6.8%
1,1974,251.37,235.95,791.33,8662,223.83,056.22,775.81,700.76971,544.51,580
Tax Ann.
-6.3%
3.5%
225.31,031.61,886.51,449.31,253.2600.6869.8-161.9423.4130.1160.4225.5
7.2%
8%
 3,219.75,349.44,3422,612.81,623.22,186.42,937.71,277.3566.91,384.11,354.5
Net Profit Ann.
7.2%
8%
971.73,219.75,349.44,3422,612.81,623.22,186.42,937.71,277.3566.91,384.11,354.5
NPM Ann. %
0.6%
-0.9%
 15.68%23.14%22.28%15.40%11.26%16.37%24.78%12.02%6.05%14.24%13.26%
EPS Adj. latest Ann.
7.2%
8.1%
 38.664.15231.319.526.235.215.36.816.616.2
Result Notes
   
Annual Reports
 
*All financials are in INR Cr and price data in INR
Total Rev. Ann.
1Y CHG
-7.9%
2Y CAGR
4.5%
3Y CAGR
8.2%
5Y CAGR
9.4%
7Y CAGR
10.8%
10Y CAGR
7.8%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
-39.8%
2Y CAGR
-13.9%
3Y CAGR
7.2%
5Y CAGR
8%
7Y CAGR
14.1%
10Y CAGR
9%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
5.6%
2Y CAGR
10.7%
3Y CAGR
9.2%
5Y CAGR
10.2%
7Y CAGR
10.4%
10Y CAGR
7.9%
Operating Expenses Annual Cr growth is lower than historical averages.

Dr. Reddy's Labs balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Dr. Reddy's Labs Mar-2026 Total Shareholders Fund is Rs 31,366 Cr which is growth of 8.7% YoY.

  • POSITIVE

    Total Assets Dr. Reddy's Labs Mar-2026 Total Assets is Rs 43,602 Cr which is growth of 13.9% YoY.

Dr. Reddy's Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
15.3%
13.1%
31,365.628,856.624,240.820,474.218,336.216,983.715,191.912,684.111,807.811,600.611,605.4
Minority Interest Liability Ann.
-
-
-----------
⌄
33.4%
66.5%
1,094782.5580.4460.9114.385.6103.4484.1572.6588.61,153.5
35.9%
19.6%
11,142.58,651.85,538.14,439.76,045.14,560.34,180.53,079.34,719.94,2584,798.7
Total Capital Plus Liabilities Ann.
19.8%
15.1%
43,602.138,290.930,359.325,374.824,495.621,629.619,475.816,247.517,100.316,447.217,557.6
⌄
14.2%
12.4%
12,099.210,429.28,800.18,119.77,350.86,745.14,845.75,082.85,392.35,382.15,044.3
⌄
29.4%
18.6%
25,078.921,787.912,543.411,586.511,01210,685.49,369.17,314.38,061.87,853.47,462.7
10.3%
11.1%
18,523.216,50317,815.913,788.313,483.610,944.210,106.78,933.29,038.58,593.810,094.9
Total Assets Ann.
19.8%
15.1%
43,602.138,290.930,359.325,374.824,495.621,629.619,475.816,247.517,100.316,447.217,557.6
Contingent Liabilities plus Commitments Ann.
14%
3%
1,229.21,500.21,763.6830.2827.41,062.81,068.6696.5716.7707.9972.6
Bonus Equity Share Capital Ann.
0%
0%
55.955.955.955.955.955.955.955.955.955.955.9
Non Current Investments Unquoted Book Value Ann.
-
-
12,361.310,301.84,033135.41,968.8
Current Investments Unquoted Book Value Ann.
-
-
3,233.52,8831,682.81,299.12,112.2
*All financials are in INR Cr and price data in INR
Total Assets Ann.
1Y CHG
13.9%
2Y CAGR
19.8%
3Y CAGR
19.8%
5Y CAGR
15.1%
7Y CAGR
15.1%
10Y CAGR
9.5%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
28.8%
2Y CAGR
41.8%
3Y CAGR
35.9%
5Y CAGR
19.6%
7Y CAGR
20.2%
10Y CAGR
8.8%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
8.7%
2Y CAGR
13.8%
3Y CAGR
15.3%
5Y CAGR
13.1%
7Y CAGR
13.8%
10Y CAGR
10.5%
Total ShareHolders Funds Annual growth is lower than historical averages.

Dr. Reddy's Labs ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

  • POSITIVE

    Book Value Per Share Dr. Reddy's Labs Mar-2026 Book Value Per Share is 376 Rs which is growth of 8.6% YoY.

  • POSITIVE

    ROE Dr. Reddy's Labs Mar-2026 ROE is 10% which is growth of 8.3% YoY.

Dr. Reddy's Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
BVSH Ann.
-32.6%
-18.1%
375.63461,453.31,228.91,101.91,020.7914.1764.1711.3699.7680.3
RoA Ann. %
-10.5%
-6.1%
7.38%13.97%14.30%10.29%6.62%10.10%15.08%7.86%3.31%8.41%7.71%
ROE Ann. %
-7%
-4.4%
10.26%18.53%17.91%12.76%8.85%12.87%19.33%10.07%4.80%11.93%11.67%
ROCE Ann. %
-9.9%
-5.7%
13.55%24.78%23.41%18.54%12.25%18.17%18.46%13.34%6.13%13.14%15.67%
⌄
           
⌄
           
⌄
           
Total Debt to Total Equity Ann.
0.20.10 0.10.10.10.10.20.20.3
*All financials are in INR Cr and price data in INR
ROE Ann. %
1Y CHG
-44.6%
2Y CAGR
-24.3%
3Y CAGR
-7%
5Y CAGR
-4.4%
7Y CAGR
0.3%
10Y CAGR
-1.3%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-47.2%
2Y CAGR
-28.2%
3Y CAGR
-10.5%
5Y CAGR
-6.1%
7Y CAGR
-0.9%
10Y CAGR
-0.4%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
1Y CHG
-10.5%
2Y CAGR
-27.1%
3Y CAGR
-18.1%
5Y CAGR
-6.7%
7Y CAGR
-7.3%
10Y CAGR
-2.1%
Current Ratio Annual is falling faster than historical averages.

Dr. Reddy's Labs cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

  • POSITIVE

    Cash From Operating Activity Dr. Reddy's Labs Mar-2026 Cash From Operating Activity is Rs 4,660 Cr which is growth of 10.3% YoY.

  • NEGATIVE

    Net Cash Flow Dr. Reddy's Labs Mar-2026 Net Cash Flow is Rs -7 Cr which is growth of -106.3% YoY.

Dr. Reddy's Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
-2.7%
5.8%
4,660.54,2253,449.75,052.91,338.73,514.21,839.22,762.11,538.61,015.92,798.2
Cash from Investing Act. Ann.
-
-
-5,784.7-5,697.6-3,430.3-3,447.6-2,038-1,458-1,689.2-550.9-1,179.91,442.5-1,961.1
Cash from Financing Act. Ann.
-
-
1,116.81,590.768.1-2,696.9505.5-794.3-224.1-2,223.1-304.4-2,581.8-693.7
-
-
-7.4118.187.5-1,091.6-193.81,261.9-74.1-11.954.3-123.4143.4
*All financials are in INR Cr and price data in INR
Cash from Operating Act. Ann.
1Y CHG
10.3%
2Y CAGR
16.2%
3Y CAGR
-2.7%
5Y CAGR
5.8%
7Y CAGR
7.8%
10Y CAGR
5.2%
Cash from Operating Activity Annual growth is higher than historical averages.
Cash from Financing Act. Ann.
1Y CHG
-29.8%
2Y CAGR
305%
Cash from Financing Annual Activity is falling faster than historical averages.

Dr. Reddy's Labs investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access